1. Academic Validation
  2. Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold

Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold

  • Bioorg Med Chem Lett. 2013 Feb 1;23(3):658-62. doi: 10.1016/j.bmcl.2012.11.118.
Claire-Lise Ciana 1 Romain Siegrist Hamed Aissaoui Léo Marx Sophie Racine Solange Meyer Christoph Binkert Ruben de Kanter Christoph Fischli Sergio Wittlin Christoph Boss
Affiliations

Affiliation

  • 1 Actelion Pharmaceuticals Ltd, Drug Discovery Chemistry and Biology, Hegenheimermattweg 91, CH-4123 Allschwil/BL, Switzerland.
Abstract

A novel series of anti-malarials, based on a hydroxy-ethyl-amine scaffold, initially identified as peptidomimetic Protease Inhibitors is described. Combination of the hydroxy-ethyl-amine anti-malarial phramacophore with the known Mannich base pharmacophore of amodiaquine (57) resulted in promising in vivo active novel derivatives.

Figures
Products